Carolyn, the conference operator, welcomes participants to Karyopharm Therapeutics' Q2 2024 financial results call. Elhan Webb, Senior VP of Investor Relations, discusses financial updates. Reshma Rangwala, Chief Medical Officer, details progress on clinical trials.